Jama Connect: Why Better MedTech AI Starts With Better Requirements

Overview: How Jama Connect’s AI-Assisted Requirements, Risk & Design Traceability Platform Transforms Medical Device Development

Jama Connect is a requirements, risk and design traceability platform that links product requirements, risk information and verification evidence throughout medical device development. It addresses a common engineering bottleneck: requirements, design decisions and test records spread across disconnected documents and systems, making changes difficult to assess and missing links harder to identify. Centralising these relationships supports a clearer view of development progress and the evidence behind design decisions.

Its AI-assisted capabilities include Jama Connect Advisor, which uses natural language processing to evaluate requirement statements against INCOSE rules and EARS notation. Guided authoring highlights wording that may be ambiguous or difficult to interpret, while batch analysis supports review across larger sets of requirements. These functions complement the platform’s requirements and traceability workflows rather than independently establishing design correctness or product safety.

Operationally, Jama Connect can reduce manual requirements-review effort and help expose unclear statements before they propagate into design and testing. Linked records support assessment of which requirements, risks and tests may need attention when a product changes. Downloadable Advisor reports also allow requirement-quality improvements to be tracked across review sessions. The practical benefits are more consistent documentation and better-informed change decisions, with human judgement remaining central to accepting recommendations and confirming evidence completeness.

Last checked on October 25, 2026: Jama Connect remains active in medical-device development, with its May 2026 MCP server launch extending product-context access to compatible AI development environments.

What is Jama Connect?

Jama Connect is a requirements, risk and design traceability platform for managing product requirements, risk controls, reviews and verification evidence throughout medical-device development. It serves MedTech and life-sciences engineering, quality and regulatory teams developing medical devices, diagnostics, software as a medical device and combination products. Its technical approach combines linked development records and change-impact visibility with Jama Connect Advisor’s natural language processing, which evaluates requirement statements against INCOSE rules and EARS notation to support clearer, more consistent requirements.

Intended Use and Limitations

• Jama Software completed a SOC 2 Type II audit performed by KirkpatrickPrice in 2022; buyers should request the latest report and confirm its scope and reporting period.

• TÜV SÜD has certified Jama Connect as a development tool for medical-device software under IEC 62304; buyers should verify coverage for their specific version and follow the associated safety manual.

• Jama’s medical-device offering supports workflows aligned with ISO 13485, ISO 14971, IEC 62304, EU MDR and FDA QMSR; this is compliance support, not certification of the customer’s product or quality system.

• Jama’s published security controls include encrypted data transfers, separate customer databases in multi-tenant environments, third-party penetration testing and restricted production access.

• Jama Connect received a TISAX Assessment Level 2 assessment through TÜV SÜD in 2025, providing an additional information-security assurance signal originating in the automotive sector.

• Jama documents customer-data location options and data return and deletion processes; buyers should confirm contractual residency, retention and deletion arrangements for their deployment.

• Francisco Partners announced a $1.2 billion acquisition agreement for Jama Software in March 2024 and currently lists it as a portfolio investment, establishing a significant ownership change rather than a funding round.